Skip to main content

Featured Article: HIV gp120/Tat protein-induced epithelial–mesenchymal transition promotes the progression of cervical lesions

New Content Item

Human immunodeficiency virus (HIV) infection is associated with an elevated incidence of cervical cancer, and accelerated disease progression, but the underlying mechanisms are not well understood. This study aimed to investigate the relationship between HIV infection and epithelial–mesenchymal transition (EMT) in cervical cancer.

Articles

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

SARS-CoV-2 and COVID-19

Find a selection of articles published across Springer Nature, as well as additional commentary and books relevant to SARS-CoV-2 and COVID-19 research.

Announcing the launch of In Review

AIDS Research and Therapy, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Aims and scope

AIDS Research and Therapy publishes studies of basic, translational, clinical, epidemiological, behavioral and educational science addressing treatment and prevention of HIV/AIDS and associated conditions. This includes studies of disease pathogenesis, novel treatment strategies and the impacts of established treatment regimans. 

Retrospective Collection: Human Retroviruses and AIDS

This retrospective collection collates recently published notable papers on HIV and retrovirus research from the journals AIDS Research and Therapy and Retrovirology.

Call for Papers

AIDS and Cancer from an African perspective

AIDS Research and Therapy and Infectious Agents and Cancer is calling for submissions to our Collection on 'AIDS and Cancer from an African perspective.' This new Collection aims to provide a dedicated venue for African oncology research.
Currently open for submissions.

Studies of HIV from Australasia, East Asia and the Pacific

AIDS Research and Therapy is calling for submissions to our Collection on 'Studies of HIV from Australasia, East Asia and the Pacific.' This Collection includes papers addressing the pathogenesis and management of HIV in Australasia, South East Asia and the South Pacific.
Currently open for submissions. 

COVID-19 and HIV: clinical presentation, outcomes and impact on clinical services

New Content ItemThis new thematic series aims to explore the clinical presentation and outcomes of COVID-19 in people with HIV, and the impact of COVID-19 on services and treatment outcomes for people living with HIV, in both high- and low-resource settings.
Currently open for submissions - submit to the series here

Treatment outcomes and paving the way for an HIV cure in Low and Middle Income Countries

New Content ItemDiscussion of HIV treatment outcomes in LMICs has historically been neglected, even though it is in these countries that a cure is most crucial. This series covers the ways treatment outcomes can be improved along the way to a HIV cure in states defined as LMICs by the WHO.
Currently open for submissions - submit to the series here

Spatial inequality, infectious diseases and disease control

Infection DynamicsCross-journal collection

This collection focuses on emerging infectious diseases in humans and animals, including the impact of antimicrobial resistance, and brings together research that investigates the relationship between spatial inequalities of all kinds and the impact and prevalence of these infectious diseases. This collection also welcomes papers that seek solutions towards disease control across areas with particularly unequal distribution of resources and opportunities.
Currently open for submissions - submit to the series here

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.1
    5-year Journal Impact Factor: 2.4
    Source Normalized Impact per Paper (SNIP): 0.837
    SCImago Journal Rank (SJR): 0.872

    Speed 2024
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 130

    Usage 2024
    Downloads: 610,396
    Altmetric mentions: 1,154